Halliburton is in a recovery-within-a-downtrend configuration: the stock is up 53.53% over the trailing year, yet it sits at $33.50, only 54.9% of the way through its 52-week range of $21.51 to $43.59, having given back a large portion of that advance since the spring. The 1-year gain reflects a powerful rally off the 52-week low, but the current price is 23.1% below the 52-week high, placing the stock in the lower-middle of its annual range — a positioning that signals neither momentum leadership nor a falling knife, but rather a market that has repriced the cycle lower. Year-to-date the stock is still up 13.18%, so the longer-term trend remains constructive even as the intermediate structure has deteriorated.

Short-term momentum is clearly negative and diverging from the 1-year trend: the stock is down 2.93% over the past month and 4.88% over three months, versus a 1-year gain of 53.53%, a classic deceleration pattern. Relative strength confirms the underperformance — HAL trails SPY by 4.15 percentage points over 1 month and 7.57 points over 3 months, and by a striking 17.31 points over 6 months, even though it leads by 38.0 points over 12 months. The 6-month change of -9.83% against SPY's +7.48% shows the stock has been in a corrective phase since roughly April, when it peaked near $43, and the recent stabilization in the low $30s (from a $31.19 July low to $33.50 now) suggests the selling pressure is easing but has not reversed.

Key technical levels are well defined: support sits at the $31.19–$31.54 zone established in late July and late September, with the 52-week low of $21.51 as the ultimate floor, while resistance lies at the $37.63 September swing high and the $43.59 52-week high above that. A breakout above $37.63 would signal the corrective phase is over and re-open the path toward the annual high, whereas a breakdown below $31.19 would confirm a lower-low structure and likely target the high-$20s. With a beta of 0.839, HAL is roughly 16% less volatile than the market — unusual for an energy services name — which argues for somewhat larger position sizing per unit of market risk, though the 27.43% max drawdown and 3.1 short ratio (elevated short interest) warn that idiosyncratic and squeeze risk remain material.

Revenue is growing modestly and re-accelerating at the margin: Q2 2026 revenue of $5.714 billion rose 3.7% year over year versus $5.510 billion in Q2 2025, and marked a sequential increase from Q1 2026's $5.402 billion and Q4 2025's $5.657 billion. The segment mix shows Completion and Production at $3.202 billion and Drilling and Evaluation at $2.512 billion, meaning the completions franchise still drives the majority of the top line and therefore the cyclical sensitivity. The multi-quarter trajectory is one of stabilization rather than robust growth — revenue has hovered in the $5.4–5.7 billion band for six quarters — which implies the investment case rests more on margin recovery and capital returns than on top-line acceleration.

Profitability has improved meaningfully off a depressed base: Q2 2026 net income of $534 million (9.35% net margin) compares with just $18 million in Q3 2025 (0.32% margin) and $472 million in Q2 2025, while gross margin of 14.07% remains below the 16.44% recorded in Q4 2025 and the 18.29% in Q4 2024. Operating margin of 13.62% in Q2 2026 is up from 12.57% in Q1 2026 and 6.36% in the trough Q3 2025, and EBITDA margin of 18.25% shows the underlying cash-earning power is intact despite GAAP margin compression from below-the-line items. The trend is one of margin recovery from a one-off-burdened quarter, but the multi-year drift in gross margin from the high-teens toward 14% is a genuine headwind that reflects pricing pressure in North American pressure pumping.

Balance-sheet and cash-flow health are solid: debt-to-equity of 0.777, a current ratio of 2.04, and $2.048 billion of cash at the end of Q2 2026 provide ample liquidity, while trailing free cash flow of $1.725 billion against a $23.7 billion market cap implies an FCF yield of roughly 7.3%. Q2 2026 operating cash flow of $824 million funded $235 million of capex, $143 million of dividends, and $208 million of buybacks, demonstrating that growth and shareholder returns are internally financed. ROE of 12.26% and ROA of 7.26% are respectable for the sector, and interest coverage of roughly 9.4x (Q2 2026 operating income of $778 million vs. $83 million interest expense) leaves comfortable headroom, though the 45.1% payout ratio and 2.44% dividend yield mean the dividend is well covered but not the primary return driver.